Menactra is a vaccine used to protect against meningococcal disease, a serious bacterial infection that can cause meningitis and other life-threatening illnesses. It is approved for use in people aged 9 months to 55 years old. The vaccine is administered as a single dose and is available in both pediatric and adult formulations. Menactra is a part of the larger vaccine market, which includes a variety of products designed to protect against a range of infectious diseases. Vaccines are an important tool in public health, helping to reduce the spread of disease and protect vulnerable populations. The Menactra market is highly competitive, with a number of companies offering similar products. These include Sanofi Pasteur, GlaxoSmithKline, Merck, Pfizer, and Novartis. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
